{"nct_id":"NCT02100852","title":"TGR-1202, a PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)","status":"COMPLETED","status_verified_date":"2019-10","start_date":"2014-03-12","start_date_type":"ACTUAL","primary_completion_date":"2017-11","primary_completion_date_type":"ACTUAL","completion_date":"2017-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TGTX"]}